Study | Acronym | Institution | Country |
---|---|---|---|
African-American Hereditary Prostate Cancer | AAHPC | National Human Genome Research Institute, National Institutes of Health | USA |
Aarhus Prostate Cancer Study | Aarhus | Aarhus University Hospital | Denmark |
The Agricultural Health Study | AHS | National Cancer Institute, National Institutes of Health | USA |
A Prospective Cohort Study of Prostate Cancer for Men with Pre-Clinical or Clinical Prostate Pathology | APCaRI | The Alberta Prostate Cancer Research Initiative | Canada |
Australian Prostate Cancer BioResource | APCB | Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Brisbane, Australia | Multi Center in Australia |
Alpha-Tocopherol Beta-Carotene (BPC3) | ATBC | National Cancer Institute, National Institutes of Health | USA |
Belfast | The Queen’s University of Belfast | UK | |
Study of Candidate Genes in Prostate Cancer, a New Strategy in the Treatment | BIOMARKCP | University of Granada | Spain |
Genetics of prostate cancer in the BioMe Biobank at the Icahn School of Medicine at Mt. Sinai | BIOME-P | Icahn School of Medicine at Mount Sinai | USA |
BioVU | Vanderbilt University Medical Cente | USA | |
Birmingham Prostate Cancer Association Study | BiPAS | Maastricht University | The Netherlands |
Birmingham, The South and East China case control study on prostate and bladder cancer | BiSEARCH | Maastricht University | The Netherlands |
BogdanLab | University of California, Los Angeles | USA | |
Canary Prostate Active Surveillance Study (PASS) | Canary PASS | Fred Hutchinson Cancer Research Center | USA |
Cancer of the Prostate and Lifestyles | CaPLife | University of Granada | Spain |
Cancer of the Prostate in Sweden | CAPS | Karolinska Institutet | Sweden |
Cardiff | Cardiff University | UK | |
Cross Cancer Institute Prostate Brachytherapy Cohort | CCI | Alberta Health Services | Canada |
French Prostate Case-Control Study | CeRePP | Centre for Research on Prostatic Diseases (CeRePP) | France |
Chinese prostate cancer case-control study | CHIPGECS | Queen Mary University of London, Second Military Medical University & Wuxi Second Hospital | China |
City Of Hope | COH | Beckman Research Institute of the City of Hope | USA |
Copenhagen Prostate Cancer Study 1 | CPCS1 | Herlev University Hospital | Denmark |
Copenhagen Prostate Cancer Study 2 | CPCS2 | Herlev University Hospital | Denmark |
Uniformed Services University-Center for Prostate Disease Research | CPDR | Uniformed Services University – Center for Prostate Disease Research | USA |
American Cancer Society Cancer Prevention Study-II (BPC3) | CPS-II | American Cancer Society, Atlanta | USA |
DIScovery of biomarkers for Clinical respOnSE to radiotherapy | DISCLOSE | National Cancer Centre Singapore | Singapore |
Einstein | Albert Einstein College of Medicine | USA | |
The Early Onset Prostate Cancer Study | EOPCS | Cancer Council Victoria | Australia |
European Prospective Investigation Into Cancer and Nutrition (BPC3) | EPIC | University of Oxford | Multi Center in EU |
European Prospective Investigation of Cancer – Norfolk | EPIC-Norfolk | University of Cambridge | UK |
EPIdemiology of Prostate CAncer | EPICAP | Environmental Cancer Epidemiology, Center for research in epidemiology and population health (CESP) INSERM, Paris-Sud University | France |
European Randomised study of Screening for Prostate Cancer | ERSPC | Erasmus MC | The Netherlands |
Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population | ESTHER | German Cancer Research Center | Germany |
Fred Hutchinson Prostate Cancer Studies | FHCRC | Fred Hutchinson Cancer Research Center | USA |
Fox Chase | American Oncologic Hospital d/b/a The Hospital of Fox Chase Cancer Center | USA | |
FPC | NorthShore University HealthSystem Research Institute | USA | |
Genetic Predictors of Adverse Radiotherapy Response | Gene-PARE | Icahn School of Medicine at Mount Sinai (Radiogenomics) | USA and Japan |
Hamburg-Zagreb | University Medical Center Hamburg-Eppendorf | Germany | |
Hannover Prostate Cancer Study | HaPCS | Hannover Biomedical Research School | Germany |
Harvard | Dana-Farber Cancer Institute | USA | |
Health Professionals Follow-up Study (BPC3) | HPFS | Harvard School of Public Health | USA |
Prostate ICGC Project | ICGC | University of East Anglia | UK |
Collaborative prostate cancer translational research project: Development of pre-clinical models of disease and non-invasive biomarkers of treatment response | IM.DM.02 | American University of Beirut | Lebanon |
Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in men at a higher genetic risk and controls | IMPACT | The Institute of Cancer Research | UK |
Portuguese Oncology Institute of Porto | IPO-Porto | Instituto Portugus de Oncologia do Porto Francisco Gentil | Portugal |
The Japan Group | Japan | Akita University School of Medicine | Japan |
John Hopkins University | JHU | Duke University | USA |
French West Indies Prostate cancer Study | KARUPROSTATE | University Hospital of Pointe-a-Pitre | France |
KLK6study | Lunenfeld-Tanenbaum Research Institute, Sinai Health System | Canada | |
Katholieke Universiteit Leuven | KULEUVEN | University of Leuven | Belgium |
University of Southern California – Los Angeles Prostate Cancer Study | LAAPC | University of Southern California | USA |
LSUHSC-NO | Louisiana State University Health Sciences Center – New Orleans | USA | |
Prostate cancer study in Malaysia | Malaysia | University of Malaya | Malaysia |
Mayo Clinic | MAYO | Mayo Clinic | USA |
Multi Case Control Study-Spain | MCC-Spain | Barcelona Institute for Global Health (ISGlobal) | Spain |
MCC-Spain-ISCIII | Instituto de Salud Carlos III | Spain | |
Melbourne Collaborative Cohort Study | MCCS | Cancer Council Victoria | Australia |
MD Anderson | The University of Texas, MD Anderson Cancer Center | USA | |
MD Anderson Cancer Center, Active surveillance trial | MDACC_AS | The University of Texas, MD Anderson Cancer Center | USA |
Malmo Diet & Cancer Study | MDC | Lund University | Sweden |
Multiethnic Cohort Study (BPC3) | MEC | University of Southern California & University of Hawai | USA |
Melbourne | Peter MacCallum Cancer Centre | Australia | |
Genetic and non-genetic risk factors for prostate cancer in Mexican men. | Mexico | Instituto Nacional de Salud Pública | Mexico |
MIAMI-WFPCS | The University of Miami – Sylvester Comprehensive Cancer Center | USA | |
The Moffitt Group | MOFFITT | H. Lee Moffitt Cancer Center and Research Institute | USA |
The Montreal Study | Montreal | Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal | Canada |
MSK/Oxford | Memorial Sloan Kettering Cancer Center, New York | USA | |
Memorial Sloan-Kettering Cancer Center | MSKCC | Memorial Sloan Kettering Cancer Center, New York | USA |
NCI_Vilnius | NCI_Vilnius | National Cancer Institute-Vilnius | Lithuania |
Nashville Men’s Health Study | NMHS | The Vanderbilt University by and through its Medical Center | USA |
Northwestern | NORTHWESTERN | Feinberg School of Medicine Northwestern University | USA |
COhort of NORway (CONOR) | Oslo | Oslo University Hospital | Norway |
North Carolina – Louisiana Prostate Cancer Project Consortium | PCaP | The University of North Carolina at Chapel Hill | USA |
Prostate Cancer study Medical University Sofia | PCMUS | Medical University of Sofia | Bulgaria |
Physicians Health Study (BPC3) | PHS | Brigham and Women’s Hospital | USA |
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (BPC3) | PLCO | National Cancer Institute, National Institutes of Health | USA |
Penn Medicine Biobank Prostate Cancer Study | PMBB-PC | University of Pennsylvania | USA |
The Poland Group | Poland | Pomeranian Medical University, Szczecin | Poland |
Prostate Project Foundation – Postgraduate Medical School, Surrey | PPF-UNIS | The University of Surrey | UK |
PRostate cAncer Genetics in Galicia | PRAGGA | Galician Foundation of Genomic Medicine, Santiago de Compostela | Spain |
PROgression in CAncer of the Prostate | PROCAP | Karolinska Institutet | Sweden |
Germline genetic profiling: correlation with targeted prostate cancer screening and treatment – The Pilot Profile Study | PROFILE | The Institute of Cancer Research | UK |
Prostate Cancer Group, Santiago, Spain | PROGReSS | Fundacion Publica Gallega Medicina Xenomica, Santiago de Compostela | Spain |
Prostate cancer : Mechanisms of progression and Treatment | ProMPT | University of Cambridge, University of Bristol & University of Oxford | UK |
Prostate Cancer Study of Austria | PROSA | Medical University of Vienna | Austria |
SNPs and prostate cancer risk in Serbian population | PROSTATSERBIA | Center for Human Molecular Genetics, University of Belgrade | Serbia |
Prostate testing for cancer and Treatment | ProtecT | University of Cambridge, University of Bristol & University of Oxford | UK |
Prostate Cancer and Environment Study | PROtEuS | Institut national de la recherche scientifique | Canada |
Prostate Cancer Supportive Care and Patient Outcomes Project (ProsCan), The QldMen and the Red Cross study | QLD | Queensland University of Technology | Australia |
Radiogenomics: Assessment of Polymorphisms for Predicting the Effects of Radiotherapy | RAPPER | The University of Manchester | UK |
Risk Factors for Prostate Cancer Study | RFPCS | Cancer Council Victoria | Australia |
San Antonio Center of Biomarkers of Risk for Prostate Cancer | SABOR | The University of Texas Health Science Center at San Antonio | USA |
Association of a Polygenic Risk Score with the risk of prostate cancer in a cohort of Brazilian patients | Sao Paulo | Faculdade de Medicina da Universidade de Sao Paulo | Brazil |
Southern Community Cohort Study | SCCS | Vanderbilt University | USA |
Study of Epidemiology and Risk factors in Cancer Heredity | SEARCH | University of Cambridge | UK |
San Francisco Bay Area Prostate Cancer Study (former NC_CCPC) | SFPCS | Cancer Prevention Institute of California and Stanford University School of Medicine | USA |
SNP Prostate Ghent | SNP_Prostate_Ghent | The Ghent University | Belgium |
Serum Proteomic analysis for biomarkers of Aggressive prostate disease in the Guernsey population | SPAG | The University of Surrey | UK |
St Georges | St George’s, University of London | UK | |
Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy | STAMPEDE | MRC Clinical Trials Unit at UCL, University College London | UK |
Stanford University School of Medicine | Stanford | Stanford University School of Medicine | USA |
Stockholm 1 | STHM1 | Karolinska Institutet | Sweden |
Stockholm 2 | STHM2 | Karolinska Institutet | Sweden |
Sweeney_DFCI | Dana Farber Cancer Institute | USA | |
Prostate Cancer Prevention Trial | SWOG-PCPT | SWOG Statistical Center, Fred Hutchinson Cancer Research Center | USA |
Selenium and Vitamin E Cancer Prevention Trial | SWOG-SELECT | SWOG Statistical Center, Fred Hutchinson Cancer Research Center | USA |
TASPRAC Study | TASPRAC | University of Tasmania | Australia |
Princess Margaret Biopsy Database | Toronto | Princess Margaret Hospital, Toronto | Canada |
UC San Diego (UCSD) | UCSD | University of California, San Diego | USA |
UGANDA | Makerere University, Kampala, Uganda | Uganda | |
U.K. Genetic Prostate Cancer Study and The Prostate Cancer Research Foundation Study | UKGPCS | The Institute of Cancer Research | UK |
Familial Prostate Cancer Study Germany | ULM | University Hospital of Ulm | Germany |
University of Southern California – Los Angeles Prostate Cancer Study | USC | University of Southern California | USA |
UTAH Study | UTAH | University of Utah | USA |
Wedge_group | University of Oxford | UK | |
Washington University Genetics Study | WUGS | Washington University School of Medicine | USA |
Wu_UHCC | Hawaii Cancer Center – University of Hawaii | USA |